| Autor: |
Jan H.M. Schellens, Tim Demuth, Kati Maharry, Eugene Tan, Savina Jaeger, Arkendu Chatterjee, Emin Avsar, Zev A. Wainberg, Heinz-Josef Lenz, Rona Yaeger, Sunil Sharma, Ferry A.L.M. Eskens, Jason E. Faris, Martijn P. Lolkema, Yasuhide Yamada, Jean-Pierre Delord, Takayuki Yoshino, Martin Schuler, Anna Spreafico, Johanna C. Bendell, Elena Elez, Josep Tabernero, Robin M.J.M. van Geel |
| Rok vydání: |
2023 |
| DOI: |
10.1158/2159-8290.22532039 |
| Popis: |
Table S1. Pharmacokinetic parameters of encorafenib and alpelisib in patients at steady state (cycle 2 day 1). Table S2. Criteria for defining dose-limited toxicities. Supplementary Figure 1. Radiological images of response for a patient treated with the dual-combination therapy of encorafenib and cetuximab. Supplementary Figure 2. Time on study by response for patients treated with the dual-combination therapy of encorafenib and cetuximab and patients treated with the triple-combination therapy of encorafenib, alpelisib, and cetuximab. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
